Merkel Cell Carcinoma: Diagnosis, Management and Controversies
Sunday, February 3, 2008, 3:00 – 5:00 pm
American Academy of Dermatology Annual Meeting – San Antonio, TX
Merkel cell carcinoma (MCC) is a frequently lethal skin cancer with a higher mortality (33%) than melanoma (15%) and evidence of rapidly increasing incidence. Management of MCC is challenging, as therapy is different in nature than for other skin malignancies and is controversial within the literature. Proper care requires coordination between dermatologists, radiation and medical oncologists, and surgeons. In this session, speakers will present the most current data on the clinical presentation, staging, pathology, and management of MCC. Representative and challenging cases will be presented to highlight treatment options and relevant data.Download the Handout
The authoritative source on Merkel cell carcinoma.
September 22, 2020
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
- Surgical excision
- Mohs micrographic surgery
- Radiation therapy
- Complementary & alternative therapies
- Clinical trials
- Adjuvant Avelumab in Merkel Cell Carcinoma Trial